Optiver Holding
CRDF icon

Optiver Holding’s Cardiff Oncology CRDF Stock Holding History

Optiver Holding’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.68K Buy
+1,657
New +$3.4K ﹤0.01% 1726
2025
Q4 		– Sell
-498
Closed -$1.03K – 2578
2025
Q3 		$1.03K Buy
+498
New +$1.38K ﹤0.01% 2495

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Optiver Holding's CRDF Position: Q1 2026 in Review

Optiver Holding opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 1,657 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #1726 among its holdings. This is a return to the name: Optiver Holding previously reported a position in CRDF as recently as Q3 2025.

Optiver Holding first reported a position in CRDF in Q3 2025 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Optiver Holding held 1,657 shares of Cardiff Oncology worth $2.68K as of Q1 2026.
  • Cardiff Oncology was a new Optiver Holding position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1726 holding.
  • Optiver Holding first reported a position in Cardiff Oncology in Q3 2025 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.